Bioelectric company Pulse Biosciences Inc (Nasdaq:PLSE) announced on Tuesday that it awarded 102,500 shares of its common stock to newly hired non-executive employees in accordance with Nasdaq Marketplace Rule 5635(c)(4).

The board's compensation committee declared non-qualified stock options to individuals who were not previously an employee or non-employee director as an inducement material to such individual's entering into employment with the company.

These stock options have an exercise price of USD5.23 per share, which is equal to the closing price of the company's common stock on 16 March 2020.

Subject to the recipient's continued employment with the company on these vesting dates, the 102,500 shares underlying the option grants will vest and become exercisable as to 25% of the shares annually beginning on the first anniversary of the recipient's start date.